Detalhe da pesquisa
1.
Morphological MRI-based features provide pretreatment survival prediction in glioblastoma.
Eur Radiol
; 29(4): 1968-1977, 2019 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-30324390
2.
Correction to: Morphological MRI-based features provide pretreatment survival prediction in glioblastoma.
Eur Radiol
; 29(5): 2729, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30547198
3.
Codeletion of 1p and 19q determines distinct gene methylation and expression profiles in IDH-mutated oligodendroglial tumors.
Acta Neuropathol
; 126(2): 277-89, 2013 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-23689617
4.
Novel genomic alterations and mechanisms associated with tumor progression in oligodendroglioma and mixed oligoastrocytoma.
J Neuropathol Exp Neurol
; 68(3): 274-85, 2009 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-19225409
5.
Identification of novel candidate target genes in amplicons of Glioblastoma multiforme tumors detected by expression and CGH microarray profiling.
Mol Cancer
; 5: 39, 2006 Sep 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-17002787
6.
Molecular classification defines 4 prognostically distinct glioma groups irrespective of diagnosis and grade.
J Neuropathol Exp Neurol
; 74(3): 241-9, 2015 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-25668564
7.
Microarray-based comparative genomic hybridization (array-CGH) as a useful tool for identifying genes involved in Glioblastoma (GB).
Methods Mol Biol
; 653: 35-45, 2010.
Artigo
em Inglês
| MEDLINE | ID: mdl-20721736
8.
Worse outcome in primary glioblastoma multiforme with concurrent epidermal growth factor receptor and p53 alteration.
Am J Clin Pathol
; 131(2): 257-63, 2009 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-19141386